{
  "event_id": "7ca07c352069",
  "ticker": "ALNY",
  "company_name": "Alnylam Pharmaceuticals",
  "drug_name": "OXLUMO",
  "result": "approved",
  "pdufa_date": "2023-09-19",
  "approval_type": {
    "status": "found",
    "value": "nda",
    "source": "websearch:ILLUMINATE-A Phase 3",
    "confidence": 0.9,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.093625",
    "error": null
  },
  "indication": {
    "status": "found",
    "value": "Primary hyperoxaluria type 1 (PH1)",
    "source": "websearch:ILLUMINATE-A Phase 3",
    "confidence": 0.85,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.093626",
    "error": null
  },
  "generic_name": {
    "status": "found",
    "value": "lumasiran",
    "source": "websearch_fda",
    "confidence": 0.85,
    "tier": 2,
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-10T00:11:33.226880",
    "error": null
  },
  "therapeutic_area": {
    "status": "found",
    "value": "Nephrology",
    "source": "websearch",
    "confidence": 0.85,
    "tier": 2,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-10T10:49:58.437229",
    "error": null
  },
  "mechanism_of_action": {
    "status": "found",
    "value": "siRNA",
    "source": "legacy_migration",
    "confidence": 0.75,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "legacy_v12"
    ],
    "last_searched": "2026-01-10T12:42:32.000713",
    "error": null,
    "note": null
  },
  "phase": {
    "status": "found",
    "value": "Phase 3",
    "source": "websearch_clinical",
    "confidence": 0.85,
    "tier": 2,
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-10T00:11:33.226880",
    "error": null
  },
  "primary_endpoint_met": {
    "status": "found",
    "value": true,
    "source": "websearch:ILLUMINATE-A Phase 3",
    "confidence": 0.85,
    "evidence": [
      "ILLUMINATE-A Phase 3"
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.093613",
    "error": null
  },
  "p_value": {
    "status": "found",
    "value": "<0.0001",
    "source": "websearch:ILLUMINATE-A Phase 3",
    "confidence": 0.9,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.093619",
    "error": null
  },
  "effect_size": {
    "status": "found",
    "value": "65% urinary oxalate reduction vs 12% placebo, 52% normalized at 6mo",
    "source": "websearch:ILLUMINATE-A Phase 3",
    "confidence": 0.85,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-09T21:20:41.093622",
    "error": null
  },
  "has_prior_crl": {
    "status": "found",
    "value": true,
    "source": "derived_from_resubmission",
    "confidence": 0.85,
    "tier": 2
  },
  "is_resubmission": {
    "status": "found",
    "value": true,
    "source": "legacy_v12",
    "confidence": 0.75,
    "evidence": [],
    "searched_sources": [
      "legacy_v12"
    ],
    "last_searched": null,
    "error": null
  },
  "pai_passed": {
    "status": "found",
    "value": true,
    "source": "derived_from_approval",
    "confidence": 0.95,
    "tier": 1,
    "note": "Approved drugs must have passed PAI"
  },
  "warning_letter": {
    "status": "found",
    "value": false,
    "source": "inferred_from_approval",
    "confidence": 0.8,
    "tier": 2,
    "note": "Approved drugs unlikely to have blocking warning letters"
  },
  "safety_signal": {
    "status": "found",
    "value": false,
    "source": "default_for_approved",
    "confidence": 0.9,
    "tier": 1,
    "note": "No blocking safety signals at approval"
  },
  "p_value_numeric": 0.0001,
  "nct_ids": [
    "NCT03681184"
  ],
  "phase3_study_names": [
    "ILLUMINATE-A: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study With an Extended Dosing Period to Evaluate the Efficacy and Safety of Lumasiran in Children and Adults With Primary Hyperoxaluria Type 1"
  ],
  "prior_crl_reason": null,
  "enrollment": {
    "value": 39,
    "status": "found",
    "source": "clinicaltrials.gov",
    "confidence": 0.95,
    "tier": 2
  },
  "fda_designations": {
    "breakthrough_therapy": true,
    "fast_track": true,
    "priority_review": true,
    "orphan_drug": true,
    "accelerated_approval": false
  },
  "adcom_info": {
    "scheduled": false,
    "held": false,
    "date": null,
    "outcome": null,
    "vote_for": null,
    "vote_against": null
  },
  "is_single_arm": {
    "value": false,
    "status": "found",
    "source": "clinicaltrials.gov",
    "confidence": 0.95,
    "tier": 2,
    "evidence": [
      "interventionModel=PARALLEL",
      "allocation=RANDOMIZED"
    ],
    "searched_sources": [
      "clinicaltrials.gov"
    ],
    "last_searched": "2026-01-11T08:28:15.180277",
    "error": null,
    "note": null,
    "has_value": true,
    "needs_retry": false,
    "is_complete": true
  },
  "trial_region": {
    "value": "global",
    "status": "found",
    "source": "clinicaltrials.gov",
    "confidence": 0.95,
    "tier": 2,
    "evidence": [
      "countries=['SWITZERLAND', 'ISRAEL', 'GERMANY', 'NETHERLANDS', 'FRANCE']..."
    ],
    "searched_sources": [
      "clinicaltrials.gov"
    ],
    "last_searched": "2026-01-11T08:28:15.180304",
    "error": null,
    "note": null,
    "has_value": true,
    "needs_retry": false,
    "is_complete": true
  },
  "is_biosimilar": {
    "value": false,
    "status": "found",
    "source": "approval_type_nda",
    "confidence": 0.9,
    "tier": 2,
    "evidence": [
      "approval_type=nda"
    ],
    "searched_sources": [
      "approval_type_nda"
    ],
    "last_searched": "2026-01-10T13:11:17.298294",
    "error": null,
    "note": null,
    "has_value": true,
    "needs_retry": false,
    "is_complete": true
  },
  "is_first_in_class": {
    "status": "not_searched",
    "value": null,
    "source": "",
    "confidence": 0.0,
    "tier": null,
    "evidence": [],
    "searched_sources": [],
    "last_searched": null,
    "error": null,
    "note": null
  },
  "crl_reason_type": {
    "status": "not_searched",
    "value": null,
    "source": "",
    "confidence": 0.0,
    "tier": null,
    "evidence": [],
    "searched_sources": [],
    "last_searched": null,
    "error": null,
    "note": null
  },
  "warning_letter_date": {
    "value": null,
    "status": "confirmed_none",
    "source": "websearch_fda",
    "confidence": 0.7,
    "tier": 3,
    "evidence": [
      "No FDA warning letter found in search"
    ],
    "searched_sources": [
      "websearch_fda"
    ],
    "last_searched": "2026-01-11T04:13:13.631640",
    "error": null
  },
  "fda_483_date": {
    "status": "not_searched",
    "value": null,
    "source": "",
    "confidence": 0.0,
    "tier": null,
    "evidence": [],
    "searched_sources": [],
    "last_searched": null,
    "error": null,
    "note": null
  },
  "fda_483_observations": {
    "status": "not_searched",
    "value": null,
    "source": "",
    "confidence": 0.0,
    "tier": null,
    "evidence": [],
    "searched_sources": [],
    "last_searched": null,
    "error": null,
    "note": null
  },
  "cdmo_name": {
    "status": "not_searched",
    "value": null,
    "source": "",
    "confidence": 0.0,
    "tier": null,
    "evidence": [],
    "searched_sources": [],
    "last_searched": null,
    "error": null,
    "note": null
  },
  "pai_date": {
    "value": null,
    "status": "not_found",
    "source": "",
    "confidence": 0.0,
    "tier": null,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-10T13:30:32.526685",
    "error": null,
    "note": null,
    "has_value": false,
    "needs_retry": true,
    "is_complete": false
  },
  "clinical_hold_history": {
    "value": null,
    "status": "confirmed_none",
    "source": "websearch_clinical_hold",
    "confidence": 0.0,
    "tier": null,
    "evidence": [],
    "searched_sources": [
      "websearch_clinical_hold"
    ],
    "last_searched": "2026-01-10T13:30:31.549617",
    "error": null,
    "note": null,
    "has_value": false,
    "needs_retry": false,
    "is_complete": true
  },
  "days_to_pdufa": -844,
  "pdufa_status": "past",
  "risk_tier": "HIGH",
  "days_calculated_at": "2026-01-10T16:59:37.137468",
  "original_case_id": "5b386fd4b2ab",
  "data_quality_score": 0.075,
  "collected_at": "2026-01-09T00:31:06.514667",
  "enriched_at": "2026-01-11T17:32:41.869075",
  "needs_manual_review": false,
  "review_reasons": [],
  "migrated_at": "2026-01-10T12:42:32.000736",
  "schema_version": "3.0",
  "adcom_scheduled": {
    "value": true,
    "status": "found",
    "source": "websearch_adcom",
    "confidence": 0.75,
    "tier": 3,
    "evidence": [
      "Review - Food and Drug Administration"
    ],
    "searched_sources": [
      "websearch_adcom"
    ],
    "last_searched": "2026-01-11T08:32:41.869063"
  },
  "adcom_vote_ratio": {
    "value": null,
    "status": "not_found",
    "source": "websearch_adcom",
    "confidence": 0.6,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "websearch_adcom"
    ],
    "last_searched": "2026-01-11T08:32:41.869071"
  },
  "breakthrough_therapy": {
    "value": true,
    "status": "found",
    "source": "websearch",
    "confidence": 0.95,
    "tier": 2,
    "evidence": [
      "FDA Approves First Drug to Treat Rare Metabolic Disorder"
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T17:26:27.109000",
    "search_status": "FOUND"
  },
  "priority_review": {
    "value": true,
    "status": "found",
    "source": "websearch",
    "confidence": 0.75,
    "tier": 2,
    "evidence": [
      "Alnylam Announces U.S. Food and Drug Administration (FDA ..."
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T17:26:29.513962",
    "search_status": "FOUND"
  },
  "fast_track": {
    "value": true,
    "status": "found",
    "source": "websearch",
    "confidence": 0.75,
    "tier": 2,
    "evidence": [
      "After being granted GIFT designation last year, Oxlumo ..."
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T17:26:34.646749",
    "search_status": "FOUND"
  },
  "orphan_drug": {
    "value": true,
    "status": "found",
    "source": "websearch",
    "confidence": 0.95,
    "tier": 2,
    "evidence": [
      "FDA Approves First Drug to Treat Rare Metabolic Disorder"
    ],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T17:26:28.203587",
    "search_status": "FOUND"
  },
  "accelerated_approval": {
    "value": null,
    "status": "not_found",
    "source": "websearch",
    "confidence": 0.0,
    "tier": 3,
    "evidence": [],
    "searched_sources": [
      "websearch"
    ],
    "last_searched": "2026-01-11T17:26:41.043112",
    "search_status": "CONFIRMED_NONE"
  }
}